Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of MT-1303 in Subjects With Inflammatory Bowel Disease
Clinical trial NCT01666327 · COMPLETED
Trial details
- NCT number
- NCT01666327
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2014-07-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.